AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Transduced tumor cells are prime candidates for becoming tumor vaccines.(Brief Article)

Vaccine Weekly

| July 10, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2002 JUL 10 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Vaccine and cancer researchers believe immunogene therapy may be a major way to use the body's own immune response system to treat and eradicate certain types of cancer.

"Immunogene therapy is a novel cancer treatment strategy based on vaccination with irradiated autologous tumor cells transduced with immunostimulatory genes," explained Ian F. Parney, University of Alberta, Edmonton, Alberta, Canada.

To better understand the prospects of using immunogene therapy in humans, Parney and colleagues have examined the responses of glioma and melanoma cells growing in culture when subjected to immunostimulatory transduction.

Parney's group transferred genes for several immunomodulatory factors, including granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-12, and B7-2, to the tumor cells with retroviruses and evaluated them for transgene expression both before and after irradiation.

Cells transduced with GM-CSF expressed similar levels of GM-CSF both before and after irradiation, but when combined with B7-2 transduction, GM-CSF expression levels were significantly lower. Interleukin-12 expression levels were initially low and fell following irradiation, while B7-2 expression levels remained high and uncompromised by radiation treatment ...

Related articles from newspapers, magazines, journals, and more
Penrose 'Parney' Albright and David Howe Join Civitas Group.
Press release article from: PR Newswire October 11, 2005 700+ words
...leading global homeland and national security strategy and investment firm, today announced the appointment of Dr. Penrose ("Parney") Albright and David Howe to the firm's management team. Albright will serve as a Managing Director of the firm and Howe...
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast...
Newspaper article from: Clinical Oncology Alert November 1, 2004 700+ words
Circulating Tumor Cells, Disease Progression, and Survival...Synopsis: The number of circulating tumor cells before treatment is an independent...breast cancer for levels of circulating tumor cells both before and after the initiation...
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast...
Newspaper article from: Clinical Oncology Alert October 1, 2004 700+ words
Circulating Tumor Cells, Disease Progression, and Survival...Synopsis: The levels of circulating tumor cells at baseline and at the first follow...breast cancer for levels of circulating tumor cells both before and after the initiation...
Aphton Reports Activity of IGN101 in Reducing Disseminating Tumor Cells From...
Press release article from: Business Wire May 16, 2005 700+ words
...ability of IGN101 to decrease circulating tumor cells in peripheral blood. Elevation of circulating tumor cells has been shown to predict short survival...29 and 57. Analyses of circulating tumor cells in peripheral blood were performed on...
Level of Circulating Tumor Cells in Bloodstream Predicts Breast Cancer...
Press release article from: PR Newswire August 18, 2004 700+ words
...the body, the level of circulating tumor cells in the bloodstream before treatment...suggest that the presence of circulating tumor cells can shed light on the prognosis of patients...technology may allow the examination of tumor cells by simply drawing blood, opening up...
Quest Diagnostics to Offer New Test to Measure Circulating Tumor Cells in...
Press release article from: PR Newswire September 20, 2004 700+ words
...that identifies and counts circulating tumor cells in blood samples from patients being...demonstrated that the number of circulating tumor cells is predictive of progression free survival...used for the enumeration of circulating tumor cells of epithelial origin in whole blood...
Enzymatic cleavage of CD95 leaves tumor cells resistant to destruction.
Newspaper article from: Biotech Week July 7, 2004 700+ words
...Enzymatic cleavage of CD95 leaves tumor cells resistant to destruction. "The ability of tumor cells to resist apoptosis-inducing signals...independent cytotoxic T-cell killing of tumor cells. We propose a new strategy by which...
Applied Imaging and StemCell Technologies Renew Exclusive Agreement to Supply...
Press release article from: PR Newswire July 20, 2004 700+ words
...the isolation of circulating tumor cells in the blood of cancer patients...isolation and analysis of circulating tumor cells, frequently associated with...technology, enriches circulating tumor cells directly from samples of cancer...
For more facts and information, see all results

Source: HighBeam Research, Transduced tumor cells are prime candidates for becoming tumor...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA